Key facts
| Price (PPV) | 68.80 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | glimépiride |
| Class | Drugs used in diabetes |
| ATC code | A10BB12 |
| Manufacturer | BOTTU S.A. |
| Presentation | Boîte de 30 |
| Nature | Médicament |
| Hospital price | 43 MAD |
| Data collected on | 9/8/2026 |
Indications
Diabète non insulino-dépendant (type 2), lorsque le régime, l'exercice physique et la réduction de poids ne suffisent pas à eux seuls à atteindre des valeurs adéquates de glycémie.
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
In Morocco, 9 other products contain the same active substance as Glema 4 mg (Glimépiride), at the same strength and in the same dosage form. For the same pack size (Boîte de 30), the cheapest is Aglim 4 mg (PHARMA5) at 62.90 MAD, i.e. 9 % less than Glema 4 mg (68.80 MAD). The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
Same pack size
| Product | Manufacturer | Pack | PPV | Unit price | Difference |
|---|---|---|---|---|---|
| Aglim 4 mg | PHARMA5 | Boite de 30 | 62.90 MAD | 2.10 / unit | −9 % |
| Amarel 4 mg | SANOFI AVENTIS MAROC | Boîte de 30 | 68.80 MAD | 2.29 / unit | — |
| Geprid 4 mg | PROMOPHARM (HIKMA) | Boîte de 30 | 68.80 MAD | 2.29 / unit | — |
| Glimiryl 4 mg | ZENITH PHARMA | Boite de 30 | 68.80 MAD | 2.29 / unit | — |
| Glyset 4 mg | GENPHARMA | Boîte de 30 | 68.80 MAD | 2.29 / unit | — |
| Odia 4 mg | SOTHEMA | Boîte de 30 | 68.80 MAD | 2.29 / unit | — |
Other pack sizes
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Aglim 4 mg | PHARMA5 | Boite de 60 | 110.70 MAD | 1.85 / unit |
| Odia 4 mg | SOTHEMA | Boîte de 60 | 121 MAD | 2.02 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Glema 4 mg
Glema 4 mg belongs to the drugs used in diabetes therapeutic class. In Morocco, this drug is marketed by BOTTU S.A. and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Glema 4 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Glema 4 mg
Answers to common questions from Moroccan patients about this drug.